NCT06638606

Brief Summary

Oral, fecal and conjunctival samples will be collected from participants and will be stored (at - 20 and - 80 ◦C) until further processing. On Day 1 and Day 2, all couples will participate in an oral, conjunctival and gut microbiota composition study. Optometry examinations will be completed for each participant Three and Six months later, oral, conjunctival and gut microbiota composition will be analyzed again with the same protocol. The participants will complete a validated Persian version of Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), global sleep assessment questionnaire (GSAQ) and Ocular Surface Disease Index. Consecutive couples will undergo a standard ophthalmology exam and specific assessments for dry eye, including non-anesthetic Schirmer's test and fluorescein tear break-up time on Day 1 and Day 90.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,740

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Oct 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Oct 2024Dec 2026

Study Start

First participant enrolled

October 8, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2026

Last Updated

January 10, 2025

Status Verified

January 1, 2025

Enrollment Period

2.2 years

First QC Date

October 9, 2024

Last Update Submit

January 8, 2025

Conditions

Keywords

DepressionAnxietyOral microbiotaSaliva cortisol

Outcome Measures

Primary Outcomes (4)

  • Sleep Pattern

    Sleep quality and quantity will be evaluated using Pittsburgh Sleep Quality Inventory.

    3 months later, sleep quality and quantity will be measured with Pittsburgh Sleep Quality Inventory

  • Optometry examinations

    3 months

  • Depression

    The BDI-II is a commonly utilized 21-item self-report inventory designed for assessing depressive symptomatology, referring to the last two weeks. Higher scores demonstrate more severe depressive symptomatology. Depression in this study was defined as a BDI-II score ≥14

    6 months later, will be measured using Beck Anxiety Inventory-II.

  • Anxiety

    BAI questionnaire has 21 items with scores ranging from 0-3 for each item, in which 0 indicates "not at all," 1 indicates "mildly, but it did not bother me much," 2 indicates "moderately, it was not pleasant at times," and 3 indicates "severely, it bothered me a lot" for all the items.

    6 months later, will be measured using Beck Anxiety Inventory

Secondary Outcomes (1)

  • Dry eye symptom

    at 3, 6 and 12 months will be measured using Ocular Surface Disease Index (OSDI) questionnaire

Study Arms (1)

A: Normal couples (have normal sleep pattern), B: Insomniac and C: hypersomniac couples

Group A: Couples with normal sleep pattern. Group B: One spouse suffers from insomnia. Group C: Once spouse suffers from hypersomnia.

Behavioral: Sleep improvement techniques

Interventions

Insomniac and hypersomniac individuals are given behavioral counselling to improve sleep.

A: Normal couples (have normal sleep pattern), B: Insomniac and C: hypersomniac couples

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All volunteer participants who had been officially married during the past six months and are in a cohabiting relationship will be invited to participate in this study together with their official spouses.

You may qualify if:

  • Sleep disorder (insomnia and hypersomnia)
  • Depressive/anxiety states

You may not qualify if:

  • Medicines known to affect gut/oral/ocular microbiota composition
  • Pregnant/pregnancy
  • Divorce during the study
  • Antibiotics use in the past month
  • Ongoing, active ocular infection, including conjunctivitis.
  • Not having any prior history with Dry eye disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Private sleep clinic

Tehran, 1961835555, Iran

Location

Related Publications (22)

  • Zhang J, Lu X, Cheng Z, Zou D, Shi W, Wang T. Alterations of conjunctival microbiota associated with orthokeratology lens wearing in myopic children. BMC Microbiol. 2023 Dec 13;23(1):397. doi: 10.1186/s12866-023-03042-1.

    PMID: 38087200BACKGROUND
  • Omar WEW, Singh G, McBain AJ, Cruickshank F, Radhakrishnan H. Gut Microbiota Profiles in Myopes and Nonmyopes. Invest Ophthalmol Vis Sci. 2024 May 1;65(5):2. doi: 10.1167/iovs.65.5.2.

    PMID: 38691091BACKGROUND
  • Wu Y, Fan H, Feng Y, Yang J, Cen X, Li W. Unveiling the gut microbiota and metabolite profiles in guinea pigs with form deprivation myopia through 16S rRNA gene sequencing and untargeted metabolomics. Heliyon. 2024 May 6;10(9):e30491. doi: 10.1016/j.heliyon.2024.e30491. eCollection 2024 May 15.

    PMID: 38756593BACKGROUND
  • Zhang Y, Zhou X, Lu Y. Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration. Front Cell Infect Microbiol. 2022 Aug 12;12:968992. doi: 10.3389/fcimb.2022.968992. eCollection 2022.

    PMID: 36034713BACKGROUND
  • Li H, Liu S, Zhang K, Zhu X, Dai J, Lu Y. Gut microbiome and plasma metabolome alterations in myopic mice. Front Microbiol. 2023 Dec 21;14:1251243. doi: 10.3389/fmicb.2023.1251243. eCollection 2023.

    PMID: 38179454BACKGROUND
  • Sun Y, Xie Y, Li J, Hou X, Sha Y, Bai S, Yu H, Liu Y, Wang G. Study on the relationship between adolescent myopia and gut microbiota via 16S rRNA sequencing. Exp Eye Res. 2024 Oct;247:110067. doi: 10.1016/j.exer.2024.110067. Epub 2024 Sep 3.

    PMID: 39233303BACKGROUND
  • Li H, Du Y, Cheng K, Chen Y, Wei L, Pei Y, Wang X, Wang L, Zhang Y, Hu X, Lu Y, Zhu X. Gut microbiota-derived indole-3-acetic acid suppresses high myopia progression by promoting type I collagen synthesis. Cell Discov. 2024 Aug 27;10(1):89. doi: 10.1038/s41421-024-00709-5.

    PMID: 39187483BACKGROUND
  • Walters EM, Phillips AJ, Hamill K, Norton PJ, Drummond SP. Anxiety predicts dyadic sleep characteristics in couples experiencing insomnia but not in couples without sleep disorders. J Affect Disord. 2020 Aug 1;273:122-130. doi: 10.1016/j.jad.2020.04.031. Epub 2020 May 12.

    PMID: 32421592BACKGROUND
  • Saini EK, Keiley MK, Fuller-Rowell TE, Duke AM, El-Sheikh M. Socioeconomic Status and Sleep among Couples. Behav Sleep Med. 2021 Mar-Apr;19(2):159-177. doi: 10.1080/15402002.2020.1721501. Epub 2020 Feb 2.

    PMID: 32008377BACKGROUND
  • Gunn HE, Buysse DJ, Hasler BP, Begley A, Troxel WM. Sleep Concordance in Couples is Associated with Relationship Characteristics. Sleep. 2015 Jun 1;38(6):933-9. doi: 10.5665/sleep.4744.

    PMID: 25581920BACKGROUND
  • Coutinho J, Pereira A, Oliveira-Silva P, Meier D, Lourenco V, Tschacher W. When our hearts beat together: Cardiac synchrony as an entry point to understand dyadic co-regulation in couples. Psychophysiology. 2021 Mar;58(3):e13739. doi: 10.1111/psyp.13739. Epub 2020 Dec 23.

    PMID: 33355941BACKGROUND
  • Liu S, Rovine MJ, Klein LC, Almeida DM. Synchrony of diurnal cortisol pattern in couples. J Fam Psychol. 2013 Aug;27(4):579-88. doi: 10.1037/a0033735.

    PMID: 23978320BACKGROUND
  • Evangelista E, Lopez R, Barateau L, Chenini S, Bosco A, Jaussent I, Dauvilliers Y. Alternative diagnostic criteria for idiopathic hypersomnia: A 32-hour protocol. Ann Neurol. 2018 Feb;83(2):235-247. doi: 10.1002/ana.25141. Epub 2018 Feb 9.

    PMID: 29323727BACKGROUND
  • Itani O, Kaneita Y, Munezawa T, Mishima K, Jike M, Nakagome S, Tokiya M, Ohida T. Nationwide epidemiological study of insomnia in Japan. Sleep Med. 2016 Sep;25:130-138. doi: 10.1016/j.sleep.2016.05.013. Epub 2016 Aug 30.

    PMID: 27823706BACKGROUND
  • Chehri A, Goldaste N, Ahmadi S, Khazaie H, Jalali A. Psychometric properties of insomnia severity index in Iranian adolescents. Sleep Sci. 2021 Apr-Jun;14(2):101-106. doi: 10.5935/1984-0063.20200045.

    PMID: 34381573BACKGROUND
  • Valles-Colomer M, Blanco-Miguez A, Manghi P, Asnicar F, Dubois L, Golzato D, Armanini F, Cumbo F, Huang KD, Manara S, Masetti G, Pinto F, Piperni E, Puncochar M, Ricci L, Zolfo M, Farrant O, Goncalves A, Selma-Royo M, Binetti AG, Becerra JE, Han B, Lusingu J, Amuasi J, Amoroso L, Visconti A, Steves CM, Falchi M, Filosi M, Tett A, Last A, Xu Q, Qin N, Qin H, May J, Eibach D, Corrias MV, Ponzoni M, Pasolli E, Spector TD, Domenici E, Collado MC, Segata N. The person-to-person transmission landscape of the gut and oral microbiomes. Nature. 2023 Feb;614(7946):125-135. doi: 10.1038/s41586-022-05620-1. Epub 2023 Jan 18.

    PMID: 36653448BACKGROUND
  • Sheng D, Li P, Xiao Z, Li X, Liu J, Xiao B, Liu W, Zhou L. Identification of bidirectional causal links between gut microbiota and narcolepsy type 1 using Mendelian randomization. Sleep. 2024 Mar 11;47(3):zsae004. doi: 10.1093/sleep/zsae004.

    PMID: 38174762BACKGROUND
  • Rakoff-Nahoum S, Foster KR, Comstock LE. The evolution of cooperation within the gut microbiota. Nature. 2016 May 12;533(7602):255-9. doi: 10.1038/nature17626. Epub 2016 Apr 25.

    PMID: 27111508BACKGROUND
  • Busch A, Roy S, Helbing DL, Colic L, Opel N, Besteher B, Walter M, Bauer M, Refisch A. Gut microbiome in atypical depression. J Affect Disord. 2024 Mar 15;349:277-285. doi: 10.1016/j.jad.2024.01.060. Epub 2024 Jan 9.

    PMID: 38211751BACKGROUND
  • Jezkova J, Sonka K, Kreisinger J, Prochazkova P, Tlaskalova-Hogenova H, Nevsimalova S, Buskova J, Merkova R, Dvorakova T, Prihodova I, Dostalova S, Roubalova R. Guardians of Rest? Investigating the gut microbiota in central hypersomnolence disorders. Sleep Med. 2024 Jan;113:95-102. doi: 10.1016/j.sleep.2023.11.024. Epub 2023 Nov 19.

    PMID: 37995475BACKGROUND
  • Han M, Yuan S, Zhang J. The interplay between sleep and gut microbiota. Brain Res Bull. 2022 Mar;180:131-146. doi: 10.1016/j.brainresbull.2021.12.016. Epub 2022 Jan 13.

    PMID: 35032622BACKGROUND
  • Wang Z, Wang Z, Lu T, Chen W, Yan W, Yuan K, Shi L, Liu X, Zhou X, Shi J, Vitiello MV, Han Y, Lu L. The microbiota-gut-brain axis in sleep disorders. Sleep Med Rev. 2022 Oct;65:101691. doi: 10.1016/j.smrv.2022.101691. Epub 2022 Aug 31.

    PMID: 36099873BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Oral, fecal and conjunctival samples will be collected from participants and will be stored (at - 20, and - 80◦C, respectively) until further processing.

MeSH Terms

Conditions

Sleep DeprivationDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

DyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Reza Rastmanesh Principal investigator, unaffilaited, PhD

    PRINCIPAL INVESTIGATOR
  • Abolfazl Sadeghinejad, MD

    STUDY DIRECTOR
  • Javid Azizi, MD

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

October 8, 2024

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

December 28, 2026

Last Updated

January 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Oral, fecal and conjunctival samples will be collected from participants and will be stored according to the standard protocols until further processing. On Day 1 and Day 2, all couples will participate in a gut microbiota composition study. Optometry examinations will be completed for each participant Three months later, gut microbiota composition will be analyzed again with the same protocol. The participants will complete a validated Persian version of Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), and global sleep assessment questionnaire (GSAQ). Insomnia in this study is defined as coexistence of both daytime dysfunction and difficulty resuming sleep. Hypersomnia is defined by a bed-rest total sleep time ≥19 hours during the 32-hour recording. SPSS software will be used to analyze the data. For more detail, contact me: r.rastmanesh@gmail.com

Locations